Cell therapy is being promoted as a promising treatment for cancer, auto-immune diseases, and genetic problems by modifying a patient’s own cells to combat the illness. However, the process of generating these treatments remains long, expensive, and prone to error. A single dose can cost upwards of $100,000, owing to the necessity for highly skilled technicians to work in clean surroundings, carefully handling sensitive tasks one patient at a time. Multiply Labs, a San Francisco company, has partnered up with NVIDIA to turn this on its head.
